Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 1Active not recruiting 1

Sponsor Class

NIH 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 1

Conditions

Carcinoma, Renal Cell 32Leukemia 26Kidney Neoplasms 25Melanoma 23Leukemia, Myeloid, Chronic-Phase 22Multiple Myeloma 17Lymphoma 17Leukemia, Myelogenous, Chronic, BCR-ABL Positive 16Neoplasms, Plasma Cell 13Lymphoma, Follicular 12Pancreatic Neoplasms 9Lymphoma, Mantle-Cell 8Leukemia, Lymphocytic, Chronic, B-Cell 8Waldenstrom Macroglobulinemia 7Neoplasms 7Lymphoma, Non-Hodgkin 7Lymphoma, Large-Cell, Immunoblastic 7Lymphoma, Large B-Cell, Diffuse 7Lymphoma, B-Cell, Marginal Zone 7Leukemia, Myeloid, Acute 7Burkitt Lymphoma 7Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Leukemia, Myeloid, Accelerated Phase 6Carcinoma, Hepatocellular 6Colorectal Neoplasms 5Urinary Bladder Neoplasms 4Recurrence 4Rectal Neoplasms 4Lung Neoplasms 4Immunoglobulin Light-chain Amyloidosis 4

Interventions

Doxorubicin 20Vincristine 17Zidovudine 13Cyclophosphamide 12Bleomycin 12Etoposide 10Rituximab 6Prednisone 6Interferon alpha-2 6Cytarabine 6Liposomes 5Filgrastim 5Dexamethasone 5tecogalan 4sargramostim 4Specimen Handling 4Methotrexate 4Magnetic Resonance Spectroscopy 4Leucovorin 4Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 4Fluorouracil 4Biopsy 4Peripheral Blood Stem Cell Transplantation 3Paclitaxel 3Nivolumab 3interferon alfa-n1 2fludarabine phosphate 2fludarabine 2cabozantinib 2Whole-Body Irradiation 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × HIV Infections × Interferon-alpha × Clear all
NCT00092222 2026-06-05

Virotherapy and Natural History Study of KHSV-Associated Multricentric Castleman s Disease With Correlates of Disease Activity

National Institutes of Health Clinical Center (CC)

Phase 2 Active not recruiting
75 enrolled
Lymphoid

Multi-centric Castleman's Disease, Macular dystrophy, corneal type 1, Lymphadenopathy, Lymphoproliferative Disorders, Neoplasms, HIV Infections

NCT00454181 2011-09-16

Treatment of Oral Warts in HIV+ Patients

Ainos, Inc. (f/k/a Amarillo Biosciences Inc.

Phase 2 Completed
59 enrolled 13 charts

Acquired Immunodeficiency Syndrome, Papilloma, Warts, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡